Global syndicate backs Prokarium’s $10M round; Bavarian Nordic to test cancer vaccine with Imfinzi; AI startup buys … – Endpoints News
Endpoints News |
Global syndicate backs Prokarium's $10M round; Bavarian Nordic to test cancer vaccine with Imfinzi; AI startup buys …
Endpoints News The UK synthetic biology player Prokarium has raised $10 million from a global syndicate of investors to back its work on oral vaccines. The money came from the Riyadh Valley Company, the venture capital arm of King Saud University, as well as Sweden's … |
